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Bioresorbable electronic stimulators are of rapidly growing interest as unusual therapeutic
platforms, i.e., bioelectronic medicines, for treating disease states, accelerating wound
healing processes and eliminating infections. Here, we present advanced materials that
support operation in these systems over clinically relevant timeframes, ultimately bioresorbing harmlessly to benign products without residues, to eliminate the need for surgical
extraction. Our ﬁndings overcome key challenges of bioresorbable electronic devices by
realizing lifetimes that match clinical needs. The devices exploit a bioresorbable dynamic
covalent polymer that facilitates tight bonding to itself and other surfaces, as a soft, elastic
substrate and encapsulation coating for wireless electronic components. We describe the
underlying features and chemical design considerations for this polymer, and the biocompatibility of its constituent materials. In devices with optimized, wireless designs, these
polymers enable stable, long-lived operation as distal stimulators in a rat model of peripheral
nerve injuries, thereby demonstrating the potential of programmable long-term electrical
stimulation for maintaining muscle receptivity and enhancing functional recovery.
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eripheral nerve injuries are among the most devastating
causes of sensorimotor deﬁcits, resulting from loss of axonal continuity, death of neuronal cells, and denervation
effects on motor, sensory, and autonomic functions1,2. Treatments for such injuries involve surgical operations that repair
nerve discontinuity with sutures or bridge with nerve grafts or
conduits. Even with such interventions, sometimes combined
with pharmacological therapies, recoveries can be unpredictable,
with unsatisfactory functional outcomes3 because (1) the associated muscle groups undergo progressive denervation atrophy,
until neuromuscular reinnervation becomes unreceptive to the
sprouting axons that regenerate across the gap4, and (2) the rates
of regeneration of nerves from lesion sites to denervated targets
are slow (~1 mm/day)5, corresponding to prolonged recovery
times and poorer functional prognosis for more proximally
located nerve injuries6.
Clinical evidence indicates that electrical stimulation of the
denervated muscles via transcutaneous electrodes or implantable
devices might improve muscle preservation and functional
outcome7,8. Transcutaneous approaches fail, however, to effectively stimulate deep muscle tissue and they, therefore, are unable
to achieve synergic muscle group contraction. Although direct
nerve interfaces based on implantable cuff electrodes offer comparatively high levels of stimulation efﬁciency9, discomfort, pain,
costs and complications can follow from surgical procedures
required to retrieve the devices after a period of use10,11. For both
transcutaneous and implantable platforms, the supporting hardware typically involves hard wired interfaces and batteries, as
inconveniences9,12–14 that often lead to non-compliance. As an
alternative, our recent work showed that wireless, battery-free,
and bioresorbable electronic stimulators can deliver recurring
proximal electrical stimulation in rodent models of nerve injury
through the initial phases of healing, with enhancements in
neuroregeneration and improvements in functional muscle
recovery15. Non-ideal mechanical properties and relatively shortlived constituent materials, however, limit the lifetimes of these
types of devices to timeframes (<6 days) that can be insufﬁcient
for nerves to surpass discontinuities associated with many traumatic injuries. Also, the proximal placement of these types of
devices provides no direct beneﬁt in reducing muscle atrophy
because electrical stimulation at these locations only promotes the
onset of motor axon regeneration, without increasing its regeneration speed16.
Here, we report (1) materials, device architectures, and integration strategies as the basis of an implantable bioresorbable
electrical stimulation platform for traumatic peripheral nerve
injuries that features soft, elastomeric mechanics and long-lived
materials, and (2) a stimulation strategy, demonstrated in rodent
models, that alleviates muscle atrophy resulting from denervation
through the application of a bioresorbable cuff electrode interface
at a location distal to the nerve injury. A critical biotechnology
aspect of these systems is in a specially synthesized bioresorbable
dynamic covalent polyurethane (b-DCPU) that serves as a substrate and bioﬂuid barrier for electronics with designs that exploit
deformable ﬁlamentary serpentine interconnects17–20. The elastomeric mechanics of these materials and their low levels of
swelling in bioﬂuids facilitate effective use as interfaces with soft
tissues/organ systems that exhibit large natural ranges of motion.
Electrical stimulation of sciatic nerves in rats repetitively over
30 days demonstrates long-term stability of operation over
timeframes relevant to recovery from traumatic nerve injuries.
Use of these platforms for multiple episodes of electrical stimulation on the distal nerve stump in a rodent model of peripheral
nerve injury (critical nerve gap of 10 mm) indicates an ability to
alleviate muscle atrophy arising from denervation. Signiﬁcant
increases in muscle weight, gait function, the size of the
2

regenerated muscle ﬁbers and the number of reinnervated neuromuscular junctions compared to those of a control group
suggest that this treatment paradigm, fundamentally enabled by
this long-lived bioresorbable system, facilitates neuromuscular
recovery, via prevention of early muscle denervation process.
Results and discussion
Bioresorbable materials, stretchable designs, and wireless,
battery-free operation. A schematic illustration of a device that
highlights the radiofrequency power harvester, stretchable
extension electrode and electrical interface to the targeted peripheral nerve appears in Fig. 1a. The bioresorbable dynamic
covalent polyurethane (b-DCPU) material offers mechanical
stretchability and minimal swelling in bioﬂuids, thereby enabling
robust operation in moving tissues, without the limitations on
operational lifetimes associated with previously reported bioresorbable nerve stimulators15. In particular, without using any
external adhesive, the thermal and stress-induced bonding processes generate strong adhesion (i.e., chemical bonding) (1)
between the top and bottom layers of the b-DCPU (~100 μm
thick) by interfacial bond exchange reactions and (2) between the
b-DCPU and other inorganic bioresorbable components by
reactions of hydroxyl groups, resulting in minimization of the risk
of bioﬂuid penetration at the interface (Fig. 1a, top left inset). The
bioresorbable harvester includes a loop antenna in a bilayer, dualcoil conﬁguration (Molybdenum (Mo), ~50 μm thick) with a
stretchable b-DCPU as a dielectric interlayer and a radiofrequency diode based on a doped membrane of monocrystalline
silicon (1.2 μm thick). A strip of bioresorbable Mo (15 μm thick,
200 μm wide) in a serpentine geometry with an opening at the
end serves as an electrical extension and connection to deliver
electrical stimuli from the receiver antenna to the nerve tissue.
The electrical interface consists of exposed Mo electrodes that
encircle the nerve (Fig. 1a, bottom right inset) and a tubular
structure of poly(lactic-co-glycolic acid) (PLGA; 75:25 (lactide:
glycolide); ~30 μm thick) with a slit along the length of one side
to facilitate surgical application over and around the nerve.
Figure 1b shows a photograph of the complete system (width:
~22 mm; length: ~60 mm; thickness: ~200 μm; weight: 370 mg),
and Fig. 1c, d highlights the soft, elastic mechanics through
pictures of the device during stretching (30%) and twisting (360°),
respectively. Figure 1e, f summarizes the electrical performance
characteristics. Radiofrequency (RF) power supplied to a
transmission antenna placed near the harvester delivers electrical
power to the interface with the nerve (Supplementary Fig. S1a).
This type of inductive wireless power transfer scheme is common
in battery-free medical impants21,22, where the use of magnetic
coupling (Fig. 1e and Supplementary Fig. S1b, c; ~16.0 MHz)
avoids signiﬁcant RF absorption by bioﬂuids or biological
tissues23. Figure 1f illustrates monophasic output (red, 17.4 V)
for continuous radiofrequency (RF) power (black, ~3.5 Vpp at a
1.5 mm coupling distance without load resistor) applied to the
transmission antenna (transmitting frequency = 14.8 MHz).
Further modulation of the RF power with a low-frequency signal,
typically 20 Hz for nerve stimulation, yields cathodic, monophasic
electrical impulses to stimulate the target nerve. (Detailed results
of electrical performance characterization of the wireless power
transfer system are in Supplementary Note 1). The output voltage
remains largely unchanged during stretching (Fig. 1g, left) and
twisting (right), with little dependence on tensile strain (left) and
twisting angle (right). The voltage does, however, depend on the
transmitted power (Supplementary Fig. S1e) and the distance
between the transmission and receiver coil (Supplementary
Fig. S1f). Speciﬁcally, increasing the distance between the coils
from 1.5 mm to 11 mm decreases the output voltage from 17 V to
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Fig. 1 Designs and properties of a long-lived, stretchable, and wireless bioresorbable electrical stimulator to enhance recovery from peripheral nerve
injuries. a Schematic illustration of the device design. The electronic component consists of three functional parts: (i) a wireless receiver that acts as a
radiofrequency power harvester and control interface, built with an inductive coil (Mo, 50 μm thick), a radiofrequency diode (Si NM active layer, 1.2 μm
thick), and an interlayer (bioresorbable dynamic covalent polyurethane (b-DCPU), 50 μm thick); (ii) stretchable extension electrodes with serpentine
structures (Mo, 15 μm thick with a 200 μm width); and (iii) a stimulation cuff (poly(lactic-co-glycolic acid) (PLGA), 30 μm thick) with exposed electrodes
at the ends as an interface to the nerve. All parts of the system, excluding the stimulation cuff, are sandwiched between two layers of bioresorbable
elastomers (b-DCPU, 100 μm). The schematic illustrations in the inset show the thermal and stress-activated bonding process for b-DCPU (top, left) and
the contact between the nerve and the stimulation cuff (bottom, right). b Optical Image of a completed device. c, d Photographic images of stretched
(30%) and twisted (360°) devices. e Radiofrequency behavior of the stimulator (black, S11; red, phase). The resonance frequency of ~16.0 MHz allows
magnetic coupling in a frequency regime with little parasitic absorption by biological tissues. n = 3 independent samples. f Example output waveform
(stimulator, red) wirelessly generated by an alternating current (sine wave) applied to the transmission coil (transmitter, black). n = 3 independent
samples. g Output voltage of a device as a function of tensile strain (left) and twist angle (right) at different distances between the harvester and
transmitter (black, 2 cm; red 5 cm; orange, 35 cm). n = 3 independent samples. h Images of accelerated dissolution of a bioresorbable wireless stimulator
associated with immersion in PBS (pH = 7.4) at 90 °C.
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2 V for a ﬁxed transmission voltage of 16.6 Vpp. At distances of
20 mm, output voltages of 2 V, corresponding to typical thresholds for nerve activation, can be generated by a transmitting
voltage of 20 Vpp at the nerve. For use in large animal models24
and in humans25 the receiver unit can be located superﬁcially
under the skin, with the deformable interconnect structure as an
interface to the stimulation site.
The essential deﬁning characteristic of this system is that the
constituent materials bioresorb in a controlled manner and
within a relevant timeframe when exposed to bioﬂuids found in
and around subcutaneous tissue. Figure 1h shows photographs of
devices collected at various times following immersion in
phosphate-buffered saline (PBS, pH 7.4) solution at an elevated
4

C+ Pristine Deg.

Sol.

temperature (90 °C) for accelerated testing. The materials largely
dissolve within 40 days, and all remaining residues completely
disappear after 50 days. The rate of degradation of the b-DCPU
can be increased by adding hydrophilic polyethyleneglycol (PEG)
in appropriate amounts (details are in Fig. 2h).
Adhesion and mechanical properties of b-DCPU. As shown in
Fig. 2a, extending the in vivo operational lifetime of bioresorbable
electronic stimulators from a few days to several months demands
solutions to daunting challenges in materials science and device
design that follow directly from requirements that the system
must be (1) electrically reliable in operation, with minimal
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Fig. 2 Mechanical, electrical, and biological characterization of a bioresorbable, stretchable substrate, and encapsulation material. a Schematic
illustration of the key requirements for the materials: dissolvability (i.e., bioresorbability), mechanical stretchability, impermeability against bioﬂuids, and
biocompatibility. Adhesion properties. b Schematic illustration of the adhesion mechanism associated with the stretchable bioresorbable dynamic covalent
polyurethane (b-DCPU) and its self-bonding behavior induced by thermally activated dynamic bond exchange reactions (left); chemically anchored bDCPU on an inorganic bioresorbable component by covalent bonding (right). c Adhesion energy between bonded pieces of b-DCPU with different
crosslinking ratios (70, 80, 90, and 100). n = 3 independent samples. The inset schematic illustrates contributions from the (i) interfacial energy and (ii)
cohesion energy. d Adhesion energy between b-DCPU 80 and other inorganic bioresorbable materials, including Si, SiO2, Mg and Mo, after the bonding
process. n = 3 independent samples. Bioﬂuid Impermeability. e Changes in resistance of a Mo electrode without encapsulation (black circle), with b-DCPU
80 (red square), and poly(lactic-co-glycolic acid) (PLGA) 65:25 encapsulation (orange triangle) as a function of the immersion time in PBS (pH 7.4)
at 37 °C. Mechanical stretchability. f Stress–strain curves for b-DCPU materials with different crosslinking ratios (olive, b-DCPU 100; orange, b-DCPU
90; red, b-DCPU 80; black, b-DCPU 70). g Changes in resistance of serpentine Mo electrodes encapsulated in b-DCPU 80 during uniaxial stretching
(up to the maximum strain of ~50%). The inset shows a photograph and FEA results of b-DCPU-encapsulated Mo serpentine electrodes under uniaxial
tensile strains of 50%. The rainbow color scale bar indicates the simulated strain values, from 0% (blue) to 0.6% (red). In vitro dissolution kinetics.
h Measured changes in weight as a function of the immersion time of b-DCPU 80 (black circle) and PEG containing b-DCPUs (polycaprolactone (PCL):
polyethyleneglycol (PEG) = 42:38, red triangle; PCL:PEG = 22:58, orange square) in PBS (pH 7.4) at physiological temperature (37 °C). In vitro
biocompatibility. i Biocompatibility of various b-DCPU samples in live/dead staining assays of healthy mouse ﬁbroblasts (L929) after 3 days of culture:
tissue culture polystyrene (TCPS); normal b-DCPU 80 (Pristine); Degraded b-DCPU 80 (Degraded or Deg.) corresponds to gel-textured b-DCPU; fully
dissolved b-DCPU 80 in PBS (Solution or Sol.). n = 5 repeated independently with similar results. j Normalized in vitro viability assay data. n = 5
independent samples. In c, d, and j the results are shown as means ± s.e.m. Data available in source data ﬁle.

permeation of bioﬂuids and parasitic leakage of current26–30, (2)
mechanically robust under various deformations, including
stretching, twisting and bending, during natural motions31, (3)
completely dissolvable (i.e., bioresorbable), at the materials level,
without adverse effect32, and (4) entirely biocompatible during
and after the treatment duration23. The operational lifetimes
reported here are signiﬁcantly longer than those of previously
reported ﬂexible or stretchable bioresorbable devices, where the
operation is limited typically to a few days (Supplementary
Note 2)15,33–35. Achieving long-lived, stable function relies critically on the b-DCPU and its dynamic covalent networks structure
for direct self-bonding17–20, as well as surface chemical approaches to ensure robust adhesion to other constituent materials. The
synthesis of the b-DCPU involves step-growth polymerization of
polycaprolactone-triol (PCL-triol) with hexamethylene diisocyanate (HDI). For both the polymerization and the bond exchange
reaction, Tin(II) 2-ethylhexanoate (Sn(Oct)2) serves as an FDAapproved biocompatible catalyst36–38. Subsequent thermal curing
(60 °C) generates a three-dimensional (3D) network structure
(Supplementary Fig. S2). (Information on the synthesis procedures and materials properties are in the Methods section and
Supplementary Note 3, respectively.) Robust self-bonding
between layers of b-DCPU arises mainly from chemical
mechanisms via thermally activated dynamic bond exchange
reactions (transesteriﬁcation and transcarbamoylation) (Fig. 2b
(left) and Supplementary Figs. S5a and S6)18,20. (Information on
the adhesion mechanism is in Supplementary Note 4). Two layers
of b-DCPU bonded in this manner show interfacial toughnesses
approaching 500 J/m2 (Fig. 2c). Increasing the crosslinking density reduces the interfacial energy corresponding to the density of
chemical bonding by decreasing the number of free hydroxyl
groups and the relative concentration of ester moieties, and it
increases the cohesion energy. Tailored formulations (isocyanate:
hydroxyl ratios of 0.8:1) balance these two factors in an optimal
way. Oxygen plasma treatment applied to other inorganic materials allows bonding to b-DCPU via reactions of surface hydroxyl
groups in a process that involves hot pressing with uncured
precursors (Fig. 2b (right) and Supplementary Fig. S5b). The
results of Fig. 2d indicate that strong adhesion (>850 J/m2) can be
achieved in this manner between b-DCPU and other inorganic
bioresorbable materials, including Si, SiO2, Mg, and Mo. These
robust interfacial bonds lead to long-term electrical stability in
simulated physiological conditions. Test structures of Mo electrodes encapsulated in b-DCPU show negligible changes in

electrical properties over 80 days in PBS (pH 7.4; 37 °C). By
comparison, otherwise similar structures formed with PLGA
encapsulation exhibit notable changes over 60 days, primarily
limited by weak interfacial adhesion (Supplementary Note 5). The
mechanics of b-DCPU are also favorable for the present applications. Depending on the density of crosslinks, the Young’s
modulus for this polymer lies between 0.5 and 3.8 MPa (Fig. 2f).
Test samples can stretch to more than 170% of their original
length, with elastic behaviors for strains larger than 25% (Supplementary Note 6). Serpentine traces of Mo (Supplementary
Fig. S8) encapsulated in b-DCPU show unchanged resistances
during stretching (ranging from 0–50%) (Fig. 2g) and under
cyclic loading (uniaxial stretching to 20% and compression to
20%, involving buckling; 5 mm/s rate; 10,000 cycles) (Fig. S9 and
Supplementary Note 6.). These collective results highlight the
properties of b-DCPU that allow devices to operate for extended
periods in a stable fashion. The rate of bioresorption of the bDCPU can be controlled over time periods from a week to several
months by modifying the composition with the addition
of hydrophilic PEG. As shown in Fig. 2h, the b-DCPU degrades
slowly, while PEG containing b-DCPU degrades much faster for
similar simulated physiological conditions (PBS; pH 7.4; 37 °C)
(Supplementary Note 7). The in vitro biocompatibility of bDCPU samples with three different degradation stages is comparable to that of the control medium (tissue culture polystyrene,
TCPS), showing no observable decrease in the in vitro viability of
mouse ﬁbroblasts after 3 days culture (Fig. 2i, j and Supplementary Note 8).
In vivo operation of the bioresorbable electrical stimulators.
The low modulus and elastomeric mechanics of this implantable
system represent features that signiﬁcantly decrease the probability for mechanical failure during in vivo operation since tissues, such as skin, muscle, and peripheral nerves, experience
strains as large as 20%, corresponding to centimeter-scale displacements during routine postural movement31. The mechanical
stability of the integrated system can be explored by ﬁnite element
analysis (FEA), as shown in Supplementary Fig. S14 for deformations associated with stretching, twisting, and out of plane
bending. For all of these and other cases of relevance for in vivo
operation, the calculated maximum strains in the constituent
materials lie below thresholds for plastic deformation or fracture.
Testing of operational stability in animal models involves
surgical implantation of the stimulators through a dorsolateral
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Fig. 3 Surgical implantation, operation, and acute demonstration of a long-lived, stretchable, and wireless bioresorbable electrical stimulator for the
sciatic nerve in a rodent model. a Surgical procedure for implanting the device. From left to right: the skin is incised; the electrical stimulation cuff is
introduced on the normal nerve; the radiofrequency harvester unit connected by stretchable extension electrodes is subcutaneously implanted to minimize
movement; the skin is sutured and the stimulation is activated with a transmitting coil. b, c Compound muscle action potential (CMAP) amplitude
measured from the gastrocnemius muscle while stimulating the sciatic nerve at various voltages (2.0–2.3 V; at 20 Hz) and frequencies (10, 15, 20 Hz; at
2.2 V). Independent devices (n = 10) in independent animals (n = 10). d Measured changes in CMAP amplitude generated by electrical stimulation at a
frequency of 20 Hz after the surgery (0 h) and after 145 h of implantation. Independent devices (n = 5) in independent animals (n = 5). e Schematic
illustration of the three different electrodes designs and the position of implantation: Type I device without extension electrode; Type II device with b-DCPU
80 encapsulated straight extension electrodes; and Type III device with b-DCPU 80 encapsulated serpentine extension electrodes. The wireless receiver
antennas of Type II and III mount on the subcutaneous region; Type I resides in the muscle adjacent to the nerve. f Distance between the harvester and
transmitter coils after implanting devices in rats (black dots) and minimum operating voltage required to induce muscle twitching for the different device
designs (red bars). Data are presented as means ± s.e.m. n = 5 independent samples. g Minimum operating voltage required to induce muscle twitching as
a function of time (black, Type II; red, Type III). n = 3 independent samples. h Images of PLGA cuff electrodes on the sciatic nerve for 6 weeks. (n = 3
independent animals per groups.) These images illustrate the release of the sciatic nerve from the bioresorbable stimulator after a therapeutic period. Data
available in source data ﬁle.

gluteal-muscle-splitting incision to expose the sciatic nerve, as
shown in Fig. 3a. Wrapping the cuff around the nerve and
securing the interface forms a tubular structure with excellent
apposition to the nerve tissue. Inserting the harvester into a
6

subcutaneous pocket created on the dorsolateral aspect of the
hindlimb and securing the harvester on top of the gluteal fascia
with bioresorbable sutures completes the implantation. Threedimensional computed tomography images of mice collected
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1 week after post-surgery conﬁrm the proper positioning of the
receiver and nerve cuff (Supplementary Fig. S15). Passing
radiofrequency power through a transmission antenna placed
adjacent to the hindlimb delivers electrical stimulation to the
nerve, with a temporal pattern deﬁned by modulation of power
delivery to the antenna. Electromyograms (EMGs) obtained from
the gastrocnemius muscle in uninjured animals conﬁrm the
ability to stimulate the sciatic nerve at levels well above threshold.
These values, as previously reported39, correspond to stimulation
of all the nerve ﬁbers via the electrodes placed around the target
sciatic nerve. Figure 3b–d shows compound muscle action
potential (CMAP) data obtained from stimulation of the sciatic
nerve with different voltages (at a frequency of 20 Hz) and
different frequencies (with an applied voltage of 2.2 V) using
monophasic pulses shortly after the surgery and after 145 h of
implantation, respectively.
The stretchable system-level properties enabled by the
serpentine Mo structures and the soft b-DCPU encapsulation
are critically important to robust, long-lived operation. Experiments with stimulators that adopt three different designs for the
Mo electrodes (Fig. 3e and Supplementary Fig. S16)—(1) without
extension (Type I), (2) with the linear extension (Type II), and (3)
with the serpentine extension (Type III)— demonstrate the
essential effects. The minimum operating voltages (i.e., transmitting voltage of primary coil) for muscle twitching, collected from
rats with these three different devices (n = 3 for each), indicate
that the Type I device requires a much higher operating voltage of
~4 V compared to that of the others (~2 V), simply because
placing the receiver of the Type I device underneath the skin
increases the distance to the transmission coil (Fig. 3f and
Supplementary Fig. S16). In all cases, the devices undergo
deformations that involve relative displacements/rotations of the
receiver and the nerve cuff, due to the natural movements of the
rat and the muscle near the sciatic nerve. As shown in Fig. 3g
(black), Type II device exhibits electrical failure after 2 days of
implantation due to mechanical fracture at the point of load
concentration. Failure analysis (Supplementary Fig. S17) suggests
that the receiver and nerve cuff parts represent the weakest points
for the devices with the Type I and II designs. By contrast, the
Type III device shows reliable operation without failure for more
than 30 days (Fig. 3g, red; Supplementary Fig. S17), relevant to
both animal studies and potential use in humans (e.g., 10 days for
rats with 1 cm nerve gap and 30 days for humans with 3 cm nerve
gap). Relatively low-operating voltages (~2 V) with negligible
changes over time during stimulation (Fig. 3g) are consistent with
tight encapsulation without signiﬁcant leakage.
Designs that decouple the nerve cuff interface from the nerve
through processes of degradation after the therapeutic period
eliminate continuing mechanical loads on the tissue imparted
through the electrical interconnect structure40. Supplementary
Fig. S18 illustrates how the nerve cuff interface decouples naturally
from the nerve as a consequence of bioresorption. The image
collected at 20 weeks after implantation shows that the PLGA cuff
undergoes bioresorption and that the b-DCPU/Mo/b-DCPU
electrode structure remains. (The white appearance is consistent
with absorbed water as part of the biodegradation process.) The
image at 30 weeks reveals that complete bioresorption of the PLGA
decouples the nerve from the b-DCPU encapsulated device. An
analogous device designed with a fast rate of bioresorption
highlights this decoupling process. Speciﬁcally, Fig. 3h shows the
behavior of a device constructed with a PLGA 50:50 (lactide:
glycolide) cuff and Mg electrode on the sciatic nerve, over a period
of 6 weeks. The image at 4 weeks after implantation indicates some
residue from the PLGA cuff, with complete bioresorption of the
PLGA and Mg at 6 weeks to electrically and mechanically decouple
this part of the system from the b-DCPU encapsulated extension
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electrode. In this way, these designs release the sciatic nerve from
the bioresorbable electronic stimulator after a therapeutic period
(i.e., functional lifetime) to allow for dissolution of remaining
bioresorbable components with relatively slow degradation rates
(i.e., degradation time) across extended timescales without adverse
mechanical loads on the nerve or immediately surrounding tissues.
Studies of the b-DCPU encapsulation in a rat model
demonstrate its biocompatibility. Histological assessments of
dorsal subcutaneous implantation show no identiﬁable immune
cells related to b-DCPU encapsulation (Supplementary Fig. S19).
Supplementary Fig. S20a shows minimal differences in changes in
body weight associated with b-DCPU implanted mice compared
with a control group. Analysis of complete blood counts and
blood chemistry tests also indicate no sign of organ damage or
injury, and no change in the electrolyte or enzyme balance
(Supplementary Fig. S20b, c). Detailed results of biocompatibility
evaluations are described in Supplementary Note 8.
Stimulation of the distal stump to alleviate muscular atrophy.
Nerve degeneration after injury occurs via the Wallerian process,
with degradation of various components of the axons and myelin
sheaths. The timeframe over which these features retain electrical
continuity after injury depends on species and the nature of the
injured nerve (Supplementary Table 1). For rat models, the EMG
response (physiologic action potential) due to distal stimulation
disappears after ~36 h, but the protection layer for conduction
(myelin) around the nerve remains for 7–10 days. Moreover, the
basal lamina remains intact throughout the period of nerve
regeneration. In this context, direct electrical stimulation via the
distal end of an injured nerve has the potential to offer improved
capabilities in preventing denervation atrophy of the innervated
muscle tissue. Considering the direction of Wallerian degeneration from the nerve injury site to the distal innervated muscle, the
cuff electrode is implanted as distal as possible, in order to trigger
effective neuromuscular junction stimulation via a remaining
conductive nerve. The rationale for this strategy follows
from clinical evidence that neuromuscular electrical stimulation
(NMES), via transcutaneous or implantable (i.e., portable) electrodes, has beneﬁcial effects on recovery from denervation injuries, by improving muscle power and function7,8, and increasing
peripheral blood ﬂow41 (Supplementary Note 8).
The following studies focus on these bioresorbable, wireless
stimulators interfaced to the distal stumps of the transected sciatic
nerves in rat models, with critical nerve gaps of 10 mm bridged by
electrospun nanoﬁbrous nerve conduits of poly(L-lactide-cocaprolactone) (Fig. 4a). The cuff electrode is applied right
proximal to the trifurcation of sciatic nerve that is secured and
insulated by PLGA 75:25 (lactide:glycolide) membrane, to prevent
current leakage outside the nerve. The therapy consists of single
(20 Hz, 200 μs pulse width, 2–4 V amplitude, 30 min for onetime) or multiple episodes (every other day for 8 days, i.e., ﬁve
times in total number after injury) of electrical stimulation,
designed approximately to mimic physiologic nerve impulses to
target muscles, with a goal of maintaining the viability of the
muscle ﬁbers and the integrity of the neuromuscular junction
(NMJ). Comparisons involve control groups, as deﬁned by
animals implanted with non-functional stimulators (no electrical
stimulation). Six weeks after sciatic nerve injury, evaluations of
functional and electrophysiological recovery determine the extent
of therapeutic beneﬁts. Measurement of wet gastrocnemius
muscle harvested at 6 weeks reveals signiﬁcant improvement of
relative muscle weight recovery (normalized to contralateral
uninjured side) in both single (36 ± 3%) and multiple (44 ± 7%)
electrical stimulation groups, as compared to the control group
(24 ± 3%) (Fig. 4b). In addition, the multiple stimulation group
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Fig. 4 Effect of multiple episodes of electrical stimulation on functional motor recovery 6 weeks after nerve injury. a Schematic illustration of
the implantation of a wireless electrical stimulator onto the distal stump of a nerve gap model in rats. A bioresorbable nerve conduit (10 mm) is bridged
between two ends of the transected sciatic nerve to realize the nerve gap model, and the cuff electrode of the stimulator is implanted on the distal nerve
stump. b Relative muscle weight (MW) recovery reveals a signiﬁcant increase in gastrocnemius muscle mass by multiple episodes of distal nerve
stimulation. n = 5 independent animals per group. c Functional gait analysis shows improved function of the injured left hindlimb, with an increase of toe
spread in the group with multiple episodes of distal nerve stimulation (circle dotted line). d, e Dynamic gait analysis further veriﬁes the improved sciatic
function index (SFI) and static sciatic index (SSI) in the group with multiple episodes of distal nerve stimulation. n = 5 independent animals per group.
f Electrophysiologic analysis reveals increased amplitude of compound muscle action potential (CMAP), with a signiﬁcant increase in the group with
multiple episodes of distal nerve stimulation. n = 5 independent animals per group. The boxplots show the median (center line), the third and ﬁrst quartiles
(upper and lower edge of the box, respectively), and the largest and smallest value that is ≤1.5 times the interquartile range (the limits of the upper and
lower whiskers, respectively). Statistical software (Version 6.0) was used for the analysis followed by a t-test and one-way ANOVA with Tukey multiple
comparison analysis (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Data available in source data ﬁle.

exhibits much higher recovery of muscle weight compared to the
single stimulation group. Gait analysis also shows improved toe
spread in the multiple stimulation group, consistent with
enhanced sciatic functional recovery (Fig. 4c). The sciatic
function indices (SFI) and static sciatic indices (SSI), together
with evaluations of functional gait analysis, indicate enhanced
functional outcomes after sciatic nerve regeneration. For SFI, the
single (−103 ± 12) and multiple stimulation (−73 ± 10) group
achieved functional recovery more extensively compared to the
control (−134 ± 9) group (Fig. 4d). For SSI, the single (−85 ± 9)
and multiple stimulation (−60 ± 5) group show similar beneﬁts
compared to the control (−107 ± 7) group (Fig. 4e). Electrophysiological analysis reveals a signiﬁcant increase in the
amplitude of CMAP in the multiple stimulation group (210 ±
70 mV), as compared to the control (80 ± 40 mV) and single
(100 ± 50 mV) stimulation groups (Fig. 4f and Supplementary
Fig. S21). Taken together, the data support the hypothesis that
multiple episodes of distal electrical stimulation have therapeutic
beneﬁts on muscle weight regeneration, sciatic functional
recovery and electrophysiology and that multiple stimulation
episodes result in an accumulative enhancement. We note that
stimulators with wired power supply but otherwise similar
designs yield results similar to the wireless devices in SFI, SSI,
muscle weight and CMAP (Supplementary Fig. S22).
Histological investigations on the regenerated nerve within the
conduit 6 weeks after injury provide information to exclude
possible effects of unintentional stimulation of the proximal nerve
stump, where stimulation has known beneﬁcial effects on
promoting the sprouting of regenerated axons42. Immunohistochemical staining reveals that the density of regenerated axons
8

from multiple episodes of the distal nerve stimulation group
remains unchanged compared to the control (non-stimulation)
group (Fig. 5a, green color for Tuj1-positive staining). These
results suggest that the therapeutic outcomes of distal nerve
stimulation follow mainly from distal inﬂuence. Further studies
examine regeneration of the innervated gastrocnemius muscle at
week 6. As shown in Fig. 5b, immunoﬂuorescent staining of the
muscle ﬁber boundary (laminin, red color) reveals a signiﬁcant
increase in the surface area of the regenerated muscle ﬁbers in the
multiple stimulation group compared to the control (nonstimulation) group. Furthermore, immunoﬂuorescent staining
of the innervated gastrocnemius muscle neuromuscular junction
(NMJ) shows that multiple episodes of distal stimulation lead to a
higher number of functional NMJs (co-localization of neuroﬁlament in red color and alpha-Bungarotoxin in green color, Fig. 5c),
in comparison with the control (non-stimulation) group.
Collectively, these ﬁndings suggest that the multiple episodes of
distal nerve stimulation result in enhancement of neuromuscular
reinnervation, without an acceleration of axon regeneration.
Denervated muscle ﬁbers exhibit spontaneous, recurring single
muscle ﬁber discharges detectable by single ﬁber electromyography43. Application of a single episode of electrical stimulus on
the distal stump, therefore, provides an additional opportunity to
investigate the mechanism of direct nerve stimulation via the
implantable electrode on the distal nerve stump. The relative
gastrocnemius muscle weight at 12 days reveals signiﬁcant
preservation of muscle weight ratio in the stimulation group
(65 ± 7.5%) compared to the control (non-stimulation) group
(50 ± 8.1%) (Fig. 6a). Gait function analysis demonstrates the
preservation of SFI in the stimulation group (−58 ± 7.8), as
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Fig. 5 Histological evidence of improved muscular recovery by multiple episodes of distal nerve stimulation 6 weeks after nerve injury. a Stained slices
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effect of motor recovery is not via accelerated axon regeneration. n = 3 repeated independently with similar results. b Immunohistochemical staining of
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color) and postsynaptic (alpha-bungarotoxin, green color) staining for the group with multiple episodes of distal nerve stimulation, indicating an enhanced
number of neuromuscular junction (NMJ) and muscle reinnervation. Naive indicates mice with uninjured nerve. n = 4 biologically independent animals. The
boxplots show the median (center line), the third and ﬁrst quartiles (upper and lower edge of the box, respectively), and the largest and smallest value that
is ≤1.5 times the interquartile range (the limits of the upper and lower whiskers, respectively). Statistical software (Version 6.0) was used for the analysis
followed by a t-test and one-way ANOVA with Tukey multiple comparison analysis (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Data available in
source data ﬁle.
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the sciatic function index (SFI) is signiﬁcantly preserved by this single stimulation. c Hematoxylin and Eosin (H&E) staining of the affected gastrocnemius
muscle ﬁber reveals an improved maintenance of muscle ﬁber surface area by single stimulation. In a, b, and c the results are shown as means ± s.e.m (n =
5 biologically independent animals per groups). Statistical software (Version 6.0) was used for analysis followed by a t-test and one-way ANOVA with
Tukey multiple comparison analysis (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Data available in source data ﬁle.

NATURE COMMUNICATIONS | (2020)11:5990 | https://doi.org/10.1038/s41467-020-19660-6 | www.nature.com/naturecommunications

9

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19660-6

compared to the control (non-stimulation) group (−82 ± 1.3) at
12 days (Fig. 6b). Gastrocnemius muscle ﬁber histological analysis
at the same time point reveals a delayed decrease in muscle ﬁber
surface area (65k ± 3k µm2) in the stimulation group when
comparing to the control (non-stimulation) group (52k ± 2k µm2)
(Fig. 6c). Taken together, the electrical stimulation delivered from
the distal nerve stump to the target muscle contributes to
preservation of innervated muscle from denervation, atrophy and
functional loss in the early phase of recovery, thus providing
more receptive muscle ﬁber for subsequent reinnervation by
motor neuron regeneration at later phase.
In conclusion, the materials, device architectures, and fabrication strategies introduced here serve as the foundations for longlived, stretchable, and wireless bioresorbable electrical stimulation
platforms designed to enhance neuromuscular reinnervation after
denervation injury. A combined set of in vitro and in vivo studies
show that bioresorbable polyurethane materials that incorporate
dynamic covalent networks serve critical roles as substrates and
encapsulation layers, to support electrical reliability, mechanical
stability, bioresorbability, and biocompatibility. These materials
and device concepts may be useful for other classes of
bioresorbable electronic implants, such as those in electrical
stimulators for bone healing, spinal cord and brain therapy, and
cardiac pacing. Evaluations on rat models of peripheral nerve
injury suggest that this paradigm for neuromuscular electrical
stimulation on the distal nerve stump maintains muscle
receptivity and preserves functional abilities for recovery, via
impeding the muscle denervation atrophy. This stimulation
strategy may be extended to dual electrical stimulation on both
proximal and distal nerve stumps to generate synergistic effects of
neuroregeneration and functional muscle recovery.
Methods
Synthesis of polycaprolactone-based polyurethane (b-DCPU). Polycaprolactone (PCL) triol (PCL-triol; average Mn ~900 g/mol), hexamethylene diisocyanate (HDI), anhydrous butyl acetate, and tin(II) 2-ethylhexanoate (Sn(Oct)2)
were obtained from Sigma-Aldrich. Supplementary Fig. S2 presents the molecular
structures of the chemical precursors (PCL-triol, HDI) and that of the ﬁnal crosslinked polymer network. The crosslinking density depends on the molar ratio of
HDI to PCL-triol. The synthesis began with melting 2.7 g of PCL-triol in a dried
glass vial at 60 °C, followed by mixing HDI (504, 576, 648, and 720 μL for b-DCPU
70, 80, 90 and 100, respectively) and butyl acetate (15 mL) until full dissolution at
60 °C. Cooling this solution and adding Sn(Oct)2 as a biocompatible catalyst (6.69
μL)38, followed by drop-casting on a hydrophobic surface prepared by immersion
of a Si wafer into 0.2 vol.% trichloro(octadecyl)silane (Sigma-Aldrich, USA) in
hexane yielded ﬁlms with thickness deﬁned by the volume and area. Substrates
were placed for 24 h in an oven at 60 °C for solvent evaporation and curing,
resulting in semi-transparent polymer ﬁlms. (Detailed property characterization of
b-DCPU is described in Supplementary Note 3) To remove potentially cytotoxic
residual reagents, we immersed the resulting b-DCPU ﬁlms in PBS (pH 7.4) at
80 °C for 2 days and thoroughly washed the sample using deionized water. We used
the as-made b-DCPU ﬁlms for degradation tests.
Preparation of bioresorbable components and assembly of wireless nerve
stimulator. Laser-cut metal coils (~50 μm thick Mg or ~15 μm thick Mo; Goodfellow, USA) transferred onto substrates of b-DCPU served as the receiving
antennas for RF power harvesting. Solid-state diffusion of boron (tube furnace at
1050 °C with N2 ﬂow) and phosphorus (tube furnace at 1050 °C with N2 ﬂow)
through a photolithographically deﬁned hard mask of SiO2 formed by plasmaenhanced chemical vapor deposition (PECVD) yielded a PIN diode with a
monocrystalline membrane of silicon derived from a silicon-on-insulator (SOI)
wafer (top silicon 1.2 μm thick, p-type; SOITEC, France). Removing the buried
oxide by immersion in hydroﬂuoric acid allowed release and transfer printing of
the membranes onto a sacriﬁcial layer of diluted poly(pyromellitic dianhydride-co4,4′-oxydianiline) (D-PI; ~200 nm) on a ﬁlm of poly(methyl methacrylate)
(PMMA; ~300 nm) on a silicon wafer. Photolithographic patterning and reactive
ion etching (RIE) determined the lateral dimensions of the doped Si for integration
into diodes. Spin-casting an overcoat of D-PI and dry etching through the
underlying D-PI and PMMA deﬁned an open mesh layout. Immersion in acetone
released the PIN diode and allowed its transfer to the PLGA substrate (~30 μm).
Oxygen RIE removed the D-PI layers during/after the transfer printing. Lasercutting of Mo foil (~15 μm thick) (or Mg foil, 50 μm thick) into 200-μm wide strips
yielded the electrical extension electrodes and interconnects to the cuff for the
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nerve interface. These bioresorbable components (RF coil, PIN diode and extension
electrode) were collected on a b-DCPU substrate and electrically interconnected
with a bioresorbable conductive wax paste44. For strong adhesion of b-DCPU to
itself and to other bioresorbable materials, the bioresorbable components on bDCPU substrate were pre-treated by oxygen plasma (200 mtorr, 200 W, 120 s;
Reactive Ion Etch Plasma System, Nordson March, CA, USA). Covering the
components with b-DCPU and hot pressing the entire system yielded a compact,
double-coil structure with openings for interconnects.
Mechanical test setup. Tensile testing was conducted by Sintech 20 G (MTS
Systems, MN, USA) with a stretching rate of 15 mm min−1 on dog-bone polymer
specimens (length: 22 mm; width: 5 mm; ASTM Standard D1708). The slopes of
stress–strain curves within the elastic range deﬁned the Young’s modulus values.
Fatigue tensile testing (RSA G2 Dynamic Mechanical Analyzer, TA Instruments,
IL, USA) used similar specimens. 180-degree peeling tests (ASTM F2256) enabled
measurements of adhesion between two layers of b-DCPU joined using a hot
pressing method. Evaluation of adhesion between b-DCPU (2.5 cm × 1 cm × 200
μm) and other materials (2.5 cm × 1 cm) used plasma-treated materials grown
(SiO2; PECVD) or anchored (Mg, Mo; super glue) on Si wafers. Peeling the bDCPU layer at 90 degrees from these materials yielded the adhesion results. In all
cases, a layer of PLA (thickness: 50 µm) bonded to the backside of b-DCPU
eliminated the energy dissipation from an elastic deformation. The stretching rates
were 60 mm min−1. Twice the plateau value of the tensile force divided by the
width of these samples deﬁned the adhesion energy45. Rheological behaviors
determined with a modular compact rheometer (Anton Parr MCR302, IL, USA;
25-mm-diameter cone plate (CP25); amplitude at 5%) deﬁned changes in
mechanical properties during degradation.
Tests of water permeation. A Mg resistor structure formed the basis of tests of
water permeation properties of candidate materials for encapsulation. Photolithography and lift-off using a positive photoresist (AZ 4620, MicroChemicals)
yielded patterns of Mg (100–500 nm) on a Si wafer with a layer of SiO2 on its
surface. A layer of Cr/Au (10/100 nm) patterned in the same manner deﬁned pads
for electrical probing. Placing a layer of encapsulation (~300 µm thick) on the Mg
resistor and sealing a well structure formed in PDMS (Sylgard 184, Dow Corning,
USA) and ﬁlled with PBS (pH 7.4) yielded a testing platform. DI water was added
periodically to maintain the concentration of PBS due to natural evaporation. The
sample was placed in an oven at 37 °C, and the resistance values of samples were
collected every hour and averaged from ﬁve different samples per group. Additional evaluations deﬁned the time-dependent changes in the resistance of Mo
traces (~15 µm thick) without encapsulation, encapsulated with b-DCPU 80
(~100 µm thick), and encapsulated with PLGA (65:35 (lactide:glycolide); Mw
40–75 K; ~100 µm thick), after immersion in PBS (pH 7.4; 37 °C).
Modeling of reactive diffusion for polymer encapsulated Mg. A onedimensional analytical model can be used to describe the reaction and diffusion
processes of a single Mg layer and polymer (PLGA or b-DCPU) encapsulated Mg
while immersed in an aqueous solution (PBS at pH 7.4, 37 °C)44,46. The model
applies since the single Mg layer thickness (h0) and the polymer/Mg specimen
thickness (h0 + hpolymer), where h0 and hpolymer are the initial thicknesses of the Mg
layer and polymer encapsulation, respectively, are much smaller compared to their
diameters (Figure in Supplementary Note 10). The resistance of Mg is given by
R ¼ R0hh0 where R0 is the initial resistance. Using the equation for normalized Mg
thickness (Eq.12 in Supplementary Note 10), the critical time tc (i.e., functional
lifetime) can be determined for the resistance to reach a critical value (i.e., R =
500 Ω) by using R ~ 87 Ω, measured from experiments, and setting hhðtc Þ ¼ 0:175.
0
The material parameters used in the polymer encapsulation model are given in
references44,46 as MMg = 24 g/mol, MH2O = 18 g/mol, ρMg = 1.738 g/cm, w0 = 1 g/
cm, kMg = 1.2 × 10−3/s, and DMg = 6.0 × 10−16 m2/s. The calculated diffusivities
Dpolymer of PLGA and b-DCPU are reported in Supplementary Note 5.
Test of polymer swelling and dissolution in bioﬂuids. Tests used square samples
(~15 mm × ~15 mm) of PLGA, b-DCPU, and PEG containing b-DCPU with various thickness (300–500 µm) immersed into bath of 0.1 M phosphate-buffered
saline (PBS, Sigma-Aldrich, USA) at temperatures of 23, 37, 60 and 80 °C.
Removing the samples at designated time intervals, rinsing them with deionized
(DI) water and drying the residual water under vacuum for one day prepared the
samples for weighing. Experiments were terminated when the b-DCPU changed
from a solid ﬁlm to a gel-like substance as a result of the degradation processes.
Comparison of the weights before and after drying under the vacuum yielded the
water uptake.
Synthesis of polycaprolactone/poly(ethylene glycol)-based polyurethane.
Poly(ethylene glycol) (PEG) (average Mn ~ 2000 g/mol) was obtained from SigmaAldrich. All reagents were used as received. By varying the ratio of PCL-triol to
PEG, different types of PEG containing b-DCPU ﬁlms were fabricated as referred
by the weight fraction of PCL-triol and PEG based on b-DCPU 80 (e.g., PCL22PEG58-U = 22 wt% PCL-triol and 58 wt% PEG). The mixture was melted at 60 °C,
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¼ 11:35 pF48. The frequency-dependent inductance (Supplementary

and then ~15 mL of butyl acetate was added, until full dissolution of the mixture
occurred at 60 °C. After cooling, 6.69 µL of the Sn(Oct)2 was added, and the
resulting liquid was drop-cast on a dry, pristine glass slide. Substrates were placed
for 24 h in an oven at 60 °C for solvent evaporation and curing, resulting in semitransparent polymer ﬁlms.

is ¼ ðωÞ12 L

In vitro biocompatibility test. A mouse ﬁbroblast cell line was purchased from
ATTC (ATCC® CCL-1™) along with their media (ATCC® 30-2003™). The cells were
maintained and cultured in 25-cm2 ﬂasks according to the manufacturer’s protocols. Cells were used for viability assay after the ﬁrst or second subculture. Three
different b-DCPU samples (~0.5 mm × ~0.5 mm) were prepared: (1) normal bDCPU (Pristine); (2) degraded b-DCPU with gel-type texture (Deg.) degraded in
PBS at 95 °C for 1 month; (3) fully dissolved b-DCPU solution (Sol.) degraded in
PBS at 95 °C for 2 months. It must be noted that Pristine does not indicate as-made
b-DCPU sample. As we aforementioned, Pristine sample was fabricated by
immersing b-DCPU in PBS (pH 7.4) at 80 °C for 2 days and thoroughly washing
the sample using deionized water to remove potentially cytotoxic residual reagents.
All samples were sterilized by EtO gas sterilizer (Anprolene® AN74i) then was
exposed to ultraviolet (UV) light for at least 30 min. After placing the sample into
the tissue culture plate (Costar-3548), cells were seeded and maintained on the
sample at a concentration of 10,000 cells/mL. After 24 h, resazurin assay47 was
performed. Resazurin sodium salt was purchased from Sigma-Aldrich (R7017) and
ﬂuorescence was measured with Cytation5 (Biotek®). For live and dead staining,
cells were cultured and maintained in the same condition for 3 days. Live/dead
viability/cytotoxicity Kit (L3224) was purchased from Invitrogen™, and cells were
stained according to the manufacturer’s protocols.

where Zi and Zr are the imaginary and real parts of the impeadance (Supplementary Fig. S2c), respectively. The power transfer efﬁciency η was calculated as

In vivo biocompatibility studies. Female CD1(8 weeks old) mice were purchased
from Charles River Laboratories. All procedures were approved by the Institutional
Animal Care and Use Committee of Northwestern University (protocol
IS00005877). The mice were anesthetized with isoﬂurane gas (~2%), HDPE and
samples of b-DCPU were implanted subcutaneously through dorsal incision.
Following 14 or 28 days of implantation, the mice were sacriﬁced for histology.
Tissue samples were ﬁxed in 10% neutral buffered formalin, embedded in parafﬁn,
sectioned and stained with Hematoxylin and Eosin (H&E) for histological analysis.
Polymorphonuclear cells and lymphocytes were identiﬁed by morphology from at
least three distinct regions by 400x ﬁelds per samples. Histological scores were
assessed as reported earlier. Five random locations were chosen for the capsule
thickness measurements from optical micrographs at ×10 magniﬁcation.
In vivo stability of b-DCPU and stimulation of normal (uninjured) sciatic
nerves in rat models. Following anesthetization, a biodegradable stimulator was
implanted and interfaced to the normal (i.e., uninjured) sciatic nerve 5 mm
proximal to the trifurcation. The surgical site was then closed as described above.
Implanted stimulators were wirelessly activated in order to deliver therapeutic
electrical stimulation (monophasic, 200 μs pulse, 20 Hz frequency, minimum
amplitude over threshold) to the normal nerve for half hour per day.

0

Fig. S2e) was calculated as
ωLðωÞ ¼

Zi ðωÞ þ ωCjZðωÞj2
;
½1 þ ωCZi ðωÞ2 þ ½ωCZr ðωÞ2

η ¼ jS21 j2 ´ 100%;

ð2Þ

ð3Þ

for different values of load resistance (Supplementary Fig. S1d).
At the self-resonance frequency, the parasitic capacitance dominates the
behavior of the wireless stimulator, making it an open circuit. The voltage between
the device then represents the full voltage value since there is no additional circuit
load sharing the voltage in the device. The wireless devices reported here operate at
a frequency that is more than three times higher than that of previously published
devices15. According to Faraday’s law of induction, the output voltage can be
determined by the rate of change of the magnetic ﬂux. Therefore, operating the
system at a higher frequency (still below the threshold when electromagnetic tissue
absorption becomes relevant) will increase the output of the wireless stimulation
sensor, thereby allowing for a reduction in the size and number of turns in the coils
for a speciﬁc voltage output.
In vivo implantation of wireless, bioresorbable stimulators and protocol for
distal nerve stimulation. Studies of in vivo therapeutic effects relied on a critical
nerve gap model of the rodent sciatic nerve. The experimental procedures with animals
were approved by the ACUC committee at UCLA (protocol number 2016-101-03) and
were carried out according to the institutional guidelines. Adult female Sprague-Dowley
rats (Charles River Laboratories) weighing 200–250 g were used in the following
experiments, and six animals were used in each group. Three experimental groups were
included: (1) No electrical stimulation (control group), (2) single electrical stimulation
(single group), and (3) multiple electrical stimulation (multiple group). All groups of
animals received the following procedures of nerve gap injury, bridged with electrospun
nanoﬁbrous nerve conduit and implanted with an electrical stimulator. An incision of
the skin and gluteal muscle of the left hindlimb revealed the sciatic nerve. A critical
nerve gap of 10 mm was created 5 mm above the trifurcation of the sciatic nerve,
repaired by electrospun nanoﬁbrous conduit with 8-0 Nylon monoﬁlament sutures.
The cuff electrode was placed at the distal stump of nerve, wrapped and secured with a
sheet of PLGA 75:25 (lactide:glycolide) membrane for insulation. The bioresorbable
receiver antenna was implanted into adjacent subcutaneous layers for wireless stimulation. After the implantation, the overlying muscle layers and skin were sutured with
4–0 absorbable sutures to close the surgery site. Immediate wireless stimulation was
delivered through radiofrequency communication with a transmission powered by a
waveform generator. Implanted stimulators were wirelessly activated to deliver electrical stimulation (monophasic, square waveform, 200 μs pulse width, 20 Hz frequency,
minimum amplitude over threshold, 2–4 V) to the injured nerve for 30 min for the
single stimulation group. For the multiple stimulation group, the stimulation was
delivered for four additional episodes on 2, 4, 6, and 8 consecutive days postoperatively.

Simulations of mechanical characteristics. The ﬁnite element analysis (FEA)
commercial software ABAQUS (Analysis User’s Manual 2016) was utilized to
optimize the interconnect layout and to study the corresponding mechanical
characteristics. The objective was to decrease the strain level in Mo wires in the
interconnect under different typical loads. The b-DCPU was modeled by hexahedron elements (C3D8R) while the thin Mo layer (15 µm thick) was modeled by
shell elements (S4R). The minimal element size was 1/8 of the width of the Mo
wires (20 µm), which ensured the convergence, and the accuracy of the simulation
results. The elastic modulus (E) and Poisson’s ratio (ν) used in the analysis were
EMo = 330 GPa, νMo = 0.29, EPU = 0.8 MPa, νPU = 0.5.

MicroCT imaging. Rats were imaged post mortem with a preclinical microCT
imaging system (nanoScan PET/CT, Mediso-USA, Boston, MA). Data acquisition
used 2.2x magniﬁcation, <60 µm focal spot, 1 × 4 binning, with 720 projection
views over a full circle, using 70 kVp/520 µA, with a 300 ms exposure time. The
projection data was reconstructed with a voxel size of 68 µm and using ﬁltered
(Butterworth ﬁlter) backprojection software from Mediso. The reconstructed data
was visualized and segmented in Amira 2019.2 (FEI, Houston, TX). A non-localmeans ﬁlter was used to reduce image artifacts.

Simulation of the electromagnetic characteristics. The commercial software
ANSYS HFSS was used to perform electromagnetic (EM) ﬁnite element analysis
and determine the inductance, Q factor, and scattering parameters (Supplementary
Fig. S2) of the bioresorbable, implantable wireless stimulator (2 layers of 17 turns
each, 12 mm diameter). Lumped ports were used to obtain the scattering parameters Snm (Supplementary Fig. S2a, b) and port impedance Znm (Fig. S2c) the
coils. An adaptive mesh (tetrahedron elements) and a spherical radiation boundary
(radius of 1000 mm) were adopted to ensure computational accuracy. The
frequency-dependent impedance of the resonant system is given by

Fabrication of nerve conduits. An electrospinning technique produced nanoﬁbrous nerve conduits49. In brief, nonwoven aligned nanoﬁbrous nerve conduits
composed of poly(L-lactide-co-caprolactone) (70:30, Purac Biomaterials), poly
(propylene glycol) (Acros Organics) and sodium acetate (Sigma) were fabricated by
using a customized electrospinning process. To make tubular scaffolds with aligned
nanoﬁbers in the longitudinal direction on luminal surface, a rotating mandrel
assembly with two electrically conductive ends and a central non-conductive section was used. The jet stream of polymer solution from the spinneret whipped
between the two conductive ends, resulting in longitudinally aligned nanoﬁbers
forming a tubular scaffold on the non-conductive portion of the mandrel. To
enhance the mechanical strength of the scaffolds, outer layers of random nanoﬁbers were deposited on this layer of longitudinally aligned ﬁbers50.

ZðωÞ ¼

R þ jωL
;
1  ω2 LC þ jωLC

ð1Þ

where, ω is the angular frequency, L is the inductance, R is the resistance, and C is
the parasitic capacitance. The quality factor (Q) was obtained from the |Z| curve in
Supplementary Fig. S2d as Qn ¼ ððΔff ÞÞ ¼ 23:8, where f, and Δf represent the working
frequency, and 3 dB bandwidth, respectively. The resistance R0 and inductance L0
Z0
QR0
at resonance are calculated as R0 ¼ 1þQ
2 ¼ 40:5 Ω and L0 ¼ ω ¼ 10:58 μH,
where Z0 is the impedance at resonance. The parasitic capacitance, considered
constant in the absence of changing electrical permittivity around the coil core,

Electrophysiology measurements. The rat sciatic nerve was re-exposed and
dissected freely from surrounding soft tissue. Electrical stimuli (single-pulse shocks,
1 mA, 0.1 ms) were applied to the intact sciatic nerve trunk at the point 5 mm
proximal to the conduit suturing point51. The amplitudes of compound muscle
action potentials (CMAPs) were recorded on the innervated gastrocnemius muscle
from 1 V to 12 V or until a supramaximal CMAP was reached. Normal CMAPs
from the non-injured right side of sciatic nerve were also recorded for normalization. Grass Tech S88X Stimulator (Astro-Med Inc.) was used for the test and
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PolyVIWE16 data acquisition software (Version 1.1, Astro-Med, Inc.) was used for
recording. Recovery rate was the ratio of amplitude of injured hindlimb’s CMAP to
contralateral normal hindlimb’s CMAP.

2.

3.
Gait function analysis. These studies used a walking track equipped with a videobased system, modiﬁed from that used in a previous study52. The apparatus
consisted of a Plexiglas chamber that was 80 cm long, 6 cm wide, and 12 cm high
with transparent glass underneath the walking track. The footprint was recorded
using an EX-F1 digital camera (Casio, Tokyo, Japan) from below the walking track.
The task was repeated until 5 or 6 satisfactory walks of at least 4 steps without
pause were obtained. In this study, only the hindlimb stepping patterns were
analyzed. The digital images obtained from each trial were processed with a
threshold setting to detect the boundary of the soles, and critical points for
determining the derivation of paw indices were determined using Matlab software
(MathWorks, Natick, MA, USA). After identifying sequential footprints, sciatic
function index53 (SFI) and static sciatic index54 (SSI) were calculated. Each parameter was averaged from at least 20 footsteps.

4.

5.
6.

7.

8.
Histological analysis and immunostaining. The nerve conduits and muscle were
harvested and ﬁxed in 4% paraformaldehyde at 4 °C for 2 h. After washing with
PBS, tissues were cryoprotected with 30% sucrose in PBS at 4 °C overnight, and
were then embedded in optimum cutting temperature (OCT) compound and were
frozen at −80 °C. The frozen samples were cryosectioned longitudinally and
transversely with the thickness of 10 μm at −20 °C. The slices were placed onto
Super frost plus slides and stored in −20 °C. Immunostaining was performed for
histological analysis. Slices were permeabilized with 0.5% Triton X-100 in PBS for
30 min, blocked with 5% Normal Donkey Serum (NDS) in PBS for 1 h, and then
samples were incubated with primary antibody against Tuj1 (1:1000, Abcam,
ab18207) in 4 °C overnight. Slides were washed three times for 15 min in PBS and
incubate with corresponding A AlexaFluor 488 goat anti-rabbit secondary antibodies (1:400, Thermoﬁsher scientiﬁc, A32731) in PBS for 1 h in room temperature. Finally, samples were cultured with DAPI(1:1000, Sigma, 28718-90-3) for
5 min. After further PBS washing, coverslips were mounted and viewed with a
ﬂuorescent microscope (Zeiss).
Muscles sections were collected on microscope slides and ﬁxed by 4% PFA for
10 min and then washed by 1x PBS three times and penetrated by 0.5% triton X100 in PBS for 30 min. Samples were incubated at room temperature for 2 h with
5% NDS for blocking. Afterward, samples were incubated with primary antibody
against laminin (1:300, Sigma-Aldrich, L9393) or neuroﬁlament (1:100, SigmaAldrich, N4142) in 4 °C overnight. Laminin and neuroﬁlament antibody was
diluted in 1% NDS and PBS, respectively. The following day, samples were washed
three times for 15 min in PBS and incubated with corresponding AlexaFluor
546 secondary antibody (1:300, Donkey anti-rabbit, Life Technologies Corporation,
A10040) and alpha-BTX (1:100, Thermo Fisher Scientiﬁc Company, B13422) in
PBS for 1 h in room temperature. Finally, samples were cultured with DAPI for
5 min. Between these steps, slides were washed with PBS three times for 15 min to
remove unbonded molecules or antibodies. Samples were mounted by ﬂuormount
media and sealed by microscope cover glass. The slides were then put in 4 °C
refrigerator overnight to allow the cover glass to set before imaging. A Zeiss
microscope was used to image laminin and NMJ staining. Both laminin and
neuroﬁlament were labeled with red and NMJ was labeled in green (alpha-BTX). Zstack was collected for the NMJ-neuroﬁlament image to show the connections
between them. ImageJ was used to measure the area of muscle ﬁber and to project
the Z-stacks to a single image (image > stacks > Z-project > Max intensity). The
image obtained from this process was used to count NMJ in sections.
Statistical analysis. Results are reported as mean ± 6 SD, unless otherwise noted.
Statistical analyses were performed using Statistical software (Version 6.0, Statsoft,
Tulsa, Oklahoma) followed by a t-test and one-way ANOVA (with Tukey multiple
comparison analysis for the difference between groups). *P < 0.05, *P < 0.01,
***P < 0.001.
Reporting summary. Further information on experimental design is available in the
Nature Research Reporting Summary linked to this article.
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